PHARMACOKINETIC COMPARISON OF PINDOLOL 30 MG RETARD AND 15 MG NORMAL TABLETS

被引:5
作者
AELLIG, WH
NUESCH, E
PACHA, W
机构
[1] SANDOZ LTD, PHARMACEUT RES & DEV, DEPT EXPT THERAPEUT, CH-4002 BASEL, SWITZERLAND
[2] SANDOZ LTD, PHARMACEUT RES & DEV, DEPT BIOPHARMACEUT, CH-4002 BASEL, SWITZERLAND
关键词
D O I
10.1007/BF00542037
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:451 / 455
页数:5
相关论文
共 13 条
[1]   BETA-ADRENOCEPTOR BLOCKING ACTIVITY AND DURATION OF ACTION OF PINDOLOL AND PROPRANOLOL IN HEALTHY VOLUNTEERS [J].
AELLIG, WH .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (02) :251-257
[3]  
BERMAN M, 1975, USERS MANUAL SAAM 26
[4]  
FRITHZ G, 1977, ACTA MED SCAND, P77
[5]   INITIATION OF ONCE-DAILY PINDOLOL TREATMENT [J].
FRITHZ, G .
BRITISH MEDICAL JOURNAL, 1978, 1 (6108) :302-302
[6]   SIMPLIFIED ANTIHYPERTENSIVE THERAPY WITH PINDOLOL RETARD [J].
KIOWSKI, W ;
STUMPE, KO ;
BUHLER, FR .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (06) :445-449
[7]  
KOLDSLAND OH, 1977, CURR THER RES CLIN E, V22, P853
[8]   PHARMACOKINETIC CRITERIA FOR EVALUATION OF RETARD FORMULATIONS [J].
MEIER, J ;
NUESCH, E ;
SCHMIDT, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (06) :429-432
[9]   A METHOD FOR FLUORIMETRIC DETERMINATION OF 4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)-INDOLE (LB46), A BETA-BLOCKING AGENT, IN PLASMA AND URINE [J].
PACHA, WL .
EXPERIENTIA, 1969, 25 (08) :802-&
[10]   DRUG DEFAULTING IN A GENERAL PRACTICE [J].
PORTER, AMW .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 1 (5638) :218-+